Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-25 @ 2:28 AM
NCT ID:
NCT01071434
Eligibility Criteria:
Inclusion Criteria:3.1.1. Eligible disease(s)/stage(s) \\AJCC Stage I, II, III or IV lung, liver or pancreatic cancer of any histology to be treated using radiotherapy will be eligible for this study.
3.1.2. Allowable type and amount of prior therapy \ Any types and amounts of prior therapy will be allowed for this study.
3.1.3. Age restriction and/or gender/ethnic restrictions \\Patients must be greater than or equal to 18 years of age. There are no gender or ethnic restrictions.
3.1.4. Life expectancy restrictions \ None.
3.1.5. ECOG or Karnofsky Performance Status \ Karnofsky performance status of 50 or greater
3.1.6. Requirements for organ and marrow function \ None.
3.1.7. Ability to understand and the willingness to sign a written informed consent document.
3.1.8. Pain-free in supine position Exclusion Criteria:3.2.1 Children (age \<18)
3.2.2 Metallic implants, embedded metallic objects, implanted biomedical devices e.g., cardiac pacemakers
3.2.3 Women who are pregnant or trying to get pregnant
3.2.4 Pain in supine position
3.2.5 Karnofsky performance status \< 50
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01071434
Study Brief:
Protocol Section:
NCT01071434